Venrock Healthcare Capital Partners III, L.P.'s Net Worth
$162 Million
Who is Venrock Healthcare Capital Partners III, L.P.?
Venrock Healthcare Capital Partners III, L.P. has an estimated net worth of $162 Million. This is based on reported shares across multiple companies, which include KalVista Pharmaceuticals, Inc., CONSTELLATION PHARMACEUTICALS INC, Altimmune, Inc., Unum Therapeutics Inc., Tricida, Inc., Vistagen Therapeutics, Inc., and Bellerophon Therapeutics, Inc..
SEC CIK
Venrock Healthcare Capital Partners III, L.P.'s CIK is 0001738048
Past Insider Trading and Trends
2022 was Venrock Healthcare Capital Partners III, L.P.'s most active year for acquiring shares with 46 total transactions. Venrock Healthcare Capital Partners III, L.P.'s most active month to acquire stocks was the month of May. 2019 was Venrock Healthcare Capital Partners III, L.P.'s most active year for disposing of shares, totalling 4 transactions. Venrock Healthcare Capital Partners III, L.P.'s most active month to dispose stocks was the month of September. 2019 saw Venrock Healthcare Capital Partners III, L.P. paying a total of $13,899,999.90 for 542,857 shares, this is the most they've acquired in one year. In 2019 Venrock Healthcare Capital Partners III, L.P. cashed out on 1,593,847 shares for a total of $14,899,957.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CONSTELLATION PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.06% | 400K |
$34.50 | $13,800,000.00 | 4.02M |
Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
KalVista Pharmaceuticals, Inc. (KALV) Snapshot price: $14.52
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 20
| |||
Form 4
| +1.82% | 86.05K |
$14.62 | $1,257,828.78 | 4.82M |
Feb 6 - Feb 8
| |||
Form 4
| +1.89% | 88.1K |
$14.47 | $1,274,792.53 | 4.74M |
Jan 30
| |||
Form 4
| +2.01% | 91.8K |
$14.05 | $1,289,802.42 | 4.65M |
Jan 25 - Jan 29
| |||
Form 4
| +2.22% | 99.13K |
$12.53 | $1,241,684.52 | 4.56M |
Jan 22 - Jan 24
| |||
Form 4
| +3.33% | 143.6K |
$12.55 | $1,801,601.80 | 4.46M |
Jan 17 - Jan 19
| |||
Form 4
| +0.61% | 26.25K |
$12.72 | $333,779.23 | 4.32M |
Jan 11 - Jan 16
| |||
Form 4
| +3.32% | 137.7K |
$12.54 | $1,726,456.92 | 4.29M |
Jan 8 - Jan 10
| |||
Form 4
| +1.45% | 59.37K |
$12.14 | $720,543.04 | 4.15M |
Jan 3 - Jan 4
| |||
Form 4
| +14.52% | 519.02K |
$12.46 | $6,465,649.95 | 4.09M |
Dec 27 - Dec 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -24.46% | -500.00K |
$28.75 | -$14,375,000.00 | 1.54M |
Mar 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Altimmune, Inc. (ALT) Snapshot price: $10.485
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -22.22% | -1.00M |
—
|
—
| 3.5M |
Feb 25
| |||
Form 4
| +50.00% | 1.5M |
$7.54 | $11,310,000.00 | 4.5M |
Jun 15
| |||
Form 4
| +76.85% | 1.3M |
$8.74 | $11,395,493.13 | 3M |
May 26 - May 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Unum Therapeutics Inc. (COGT) Snapshot price: $5.865
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.55% | 451K |
$2.52 | $1,137,120.00 | 4.36M |
Aug 14 - Aug 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tricida, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -63.23% | -6.45M |
$0.54 | -$3,501,546.58 | 3.75M |
Oct 24 - Oct 26
| |||
Form 4
| +3.57% | 351.87K |
$10.68 | $3,756,273.14 | 10.2M |
Oct 18 - Oct 19
| |||
Form 4
| +1.81% | 174.97K |
$11.68 | $2,043,302.16 | 9.85M |
Oct 13 - Oct 17
| |||
Form 4
| +1.41% | 134.21K |
$11.91 | $1,597,983.46 | 9.68M |
Oct 7 - Oct 11
| |||
Form 4
| +2.39% | 223.1K |
$11.81 | $2,634,811.00 | 9.54M |
Oct 4
| |||
Form 4
| +4.92% | 436.92K |
$10.75 | $4,697,069.76 | 9.32M |
Sep 29 - Oct 3
| |||
Form 4
| +7.08% | 587.21K |
$8.90 | $5,225,027.84 | 8.88M |
Sep 26 - Sep 28
| |||
Form 4
| +9.03% | 686.71K |
$11.53 | $7,918,744.29 | 8.29M |
Sep 2 - Sep 7
| |||
Form 4
| +0.66% | 50K |
$12.20 | $610,000.00 | 7.61M |
Aug 30
| |||
Form 4
| +0.25% | 18.9K |
$9.21 | $174,069.00 | 7.56M |
Jul 29
| |||
Form 4
| +0.99% | 74.2K |
$9.26 | $687,181.05 | 7.54M |
Jul 21 - Jul 25
| |||
Form 4
| +2.05% | 150K |
$9.18 | $1,377,250.00 | 7.46M |
Jul 18 - Jul 20
| |||
Form 4
| +1.31% | 94.57K |
$9.88 | $934,815.33 | 7.31M |
Jul 12 - Jul 14
| |||
Form 4
| +1.24% | 88.2K |
$9.61 | $847,230.00 | 7.22M |
Jul 1 - Jul 5
| |||
Form 4
| +0.89% | 62.87K |
$9.76 | $613,509.92 | 7.13M |
Jun 28 - Jun 30
| |||
Form 4
| +7.48% | 492.02K |
$10.37 | $5,101,091.60 | 7.07M |
Jun 22 - Jun 24
| |||
Form 4
| +0.09% | 5.95K |
$9.69 | $57,665.19 | 6.58M |
Jun 16
| |||
Form 4
| +1.83% | 118.05K |
$8.57 | $1,011,461.14 | 6.57M |
Jun 10 - Jun 14
| |||
Form 4
| +10.03% | 588.02K |
$9.65 | $5,672,963.18 | 6.45M |
Jun 7 - Jun 9
| |||
Form 4
| +3.36% | 190.87K |
$9.16 | $1,748,709.45 | 5.87M |
Jun 2 - Jun 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||